Capital Group Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.78M | Buy |
17,738
+388
| +2% | +$127K | 1.03% | 25 |
|
|
2025
Q1 | $4.68M | Buy |
17,350
+179
| +1% | +$48.3K | 0.96% | 31 |
|
|
2024
Q4 | $4.04M | Sell |
17,171
-4,176
| -20% | -$983K | 0.77% | 35 |
|
|
2024
Q3 | $5.87M | Buy |
21,347
+1,777
| +9% | +$489K | 1.18% | 23 |
|
|
2024
Q2 | $4.76M | Buy |
19,570
+3,397
| +21% | +$825K | 1.03% | 27 |
|
|
2024
Q1 | $2.42M | Sell |
16,173
-16,251
| -50% | -$2.43M | 0.43% | 69 |
|
|
2023
Q4 | $6.21M | Sell |
32,424
-21,092
| -39% | -$4.04M | 0.65% | 48 |
|
|
2023
Q3 | $9.48M | Buy |
53,516
+34,048
| +175% | +$6.03M | 0.62% | 68 |
|
|
2023
Q2 | $3.7M | Hold |
19,468
| – | – | 0.18% | 96 |
|
|
2023
Q1 | $3.9M | Sell |
19,468
-2,582
| -12% | -$517K | 0.21% | 96 |
|
|
2022
Q4 | $5.24M | Buy |
+22,050
| New | +$5.24M | 0.2% | 90 |
|